These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 9197270)

  • 1. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal.
    Rodríguez de Fonseca F; Carrera MR; Navarro M; Koob GF; Weiss F
    Science; 1997 Jun; 276(5321):2050-4. PubMed ID: 9197270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing hormone (CRH) mRNA expression in rat central amygdala in cannabinoid tolerance and withdrawal: evidence for an allostatic shift?
    Caberlotto L; Rimondini R; Hansson A; Eriksson S; Heilig M
    Neuropsychopharmacology; 2004 Jan; 29(1):15-22. PubMed ID: 12968131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.
    Rodríguez de Fonseca F; Rubio P; Menzaghi F; Merlo-Pich E; Rivier J; Koob GF; Navarro M
    J Pharmacol Exp Ther; 1996 Jan; 276(1):56-64. PubMed ID: 8558457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
    González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
    Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of cannabinoid 1 receptors reverses the anxiety-like behavior induced by central injections of corticotropin-releasing factor and cocaine withdrawal.
    Kupferschmidt DA; Newman AE; Boonstra R; Erb S
    Neuroscience; 2012 Mar; 204():125-33. PubMed ID: 21784132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid CB₁ receptor restrains accentuated activity of hypothalamic corticotropin-releasing factor and brainstem tyrosine hydroxylase neurons in endotoxemia-induced hypophagia in rats.
    Rorato R; Reis WL; de Carvalho Borges B; Antunes-Rodrigues J; Elias LL
    Neuropharmacology; 2012 Jul; 63(1):154-60. PubMed ID: 22138163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A.
    Aceto MD; Scates SM; Lowe JA; Martin BR
    Eur J Pharmacol; 1995 Aug; 282(1-3):R1-2. PubMed ID: 7498260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat.
    Navarro M; Hernández E; Muñoz RM; del Arco I; Villanúa MA; Carrera MR; Rodríguez de Fonseca F
    Neuroreport; 1997 Jan; 8(2):491-6. PubMed ID: 9080435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats.
    Navarro M; Chowen J; Rocío A Carrera M; del Arco I; Villanúa MA; Martin Y; Roberts AJ; Koob GF; de Fonseca FR
    Neuroreport; 1998 Oct; 9(15):3397-402. PubMed ID: 9855288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats.
    Funk CK; O'Dell LE; Crawford EF; Koob GF
    J Neurosci; 2006 Nov; 26(44):11324-32. PubMed ID: 17079660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methamphetamine abstinence induces changes in μ-opioid receptor, oxytocin and CRF systems: Association with an anxiogenic phenotype.
    Georgiou P; Zanos P; Garcia-Carmona JA; Hourani S; Kitchen I; Laorden ML; Bailey A
    Neuropharmacology; 2016 Jun; 105():520-532. PubMed ID: 26896754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical withdrawal in rats tolerant to delta 9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist.
    Tsou K; Patrick SL; Walker JM
    Eur J Pharmacol; 1995 Jul; 280(3):R13-5. PubMed ID: 8566091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats.
    Sarnyai Z; Bíró E; Gardi J; Vecsernyés M; Julesz J; Telegdy G
    Brain Res; 1995 Mar; 675(1-2):89-97. PubMed ID: 7796157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats.
    George O; Ghozland S; Azar MR; Cottone P; Zorrilla EP; Parsons LH; O'Dell LE; Richardson HN; Koob GF
    Proc Natl Acad Sci U S A; 2007 Oct; 104(43):17198-203. PubMed ID: 17921249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid withdrawal is dependent upon PKA activation in the cerebellum.
    Tzavara ET; Valjent E; Firmo C; Mas M; Beslot F; Defer N; Roques BP; Hanoune J; Maldonado R
    Eur J Neurosci; 2000 Mar; 12(3):1038-46. PubMed ID: 10762335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol.
    Tanda G; Loddo P; Di Chiara G
    Eur J Pharmacol; 1999 Jul; 376(1-2):23-6. PubMed ID: 10440085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats.
    Richter RM; Weiss F
    Synapse; 1999 Jun; 32(4):254-61. PubMed ID: 10332801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of cannabinoid withdrawal syndrome by lithium: involvement of oxytocinergic neuronal activation.
    Cui SS; Bowen RC; Gu GB; Hannesson DK; Yu PH; Zhang X
    J Neurosci; 2001 Dec; 21(24):9867-76. PubMed ID: 11739594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis.
    Merlo Pich E; Lorang M; Yeganeh M; Rodriguez de Fonseca F; Raber J; Koob GF; Weiss F
    J Neurosci; 1995 Aug; 15(8):5439-47. PubMed ID: 7643193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marijuana: harder than thought?
    Wickelgren I
    Science; 1997 Jun; 276(5321):1967-8. PubMed ID: 9221496
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.